Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

235.29
Delayed Data
As of Mar 23
 +1.30 / +0.56%
Today’s Change
184.50
Today|||52-Week Range
282.59
+12.04%
Year-to-Date
All Eyes On Washington: US Futures Rise On Hope Healthcare Vote Will Pass
7:20am / Investing Channel - Paid Partner Content
Adding to AGN Long
Mar 23 / TheStreet.com - Paid Partner Content
The Most Attractive Value Stock There Is?
Mar 23 / GuruFocus News - Paid Partner Content
Allergan's Restasis Now Available in Multidose Bottle in U.S.
Mar 23 / Zacks.com - Paid Partner Content
The Good, the Bad and the Ugly (Early Afternoon Edition)
Mar 23 / TheStreet.com - Paid Partner Content
Companies Spend Less on Share Buybacks for Second Year in 2016
Mar 23 / GuruFocus News - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 23 / GuruFocus News - Paid Partner Content
Corporate Share Repurchases Decline for 2nd Year in a Row
Mar 22 / GuruFocus News - Paid Partner Content
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 21 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close233.99
Today’s open234.13
Day’s range233.00 - 237.20
Volume2,639,098
Average volume (3 months)4,249,656
Market cap$78.9B
Dividend yield1.19%
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.81%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.32+1.03%
ABTAbbott Laboratories-0.04-0.09%
NVONovo Nordisk-0.75-2.21%
LLYEli Lilly and Co+0.06+0.07%
Data as of 03/23/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.39
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs